Winslow Evans & Crocker’s Elanco Animal Health ELAN Stock Holding History

Winslow Evans & Crocker’s Portfolio ELAN Stock Details ELAN Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	$73K	Buy	+2,380	New	+$72.6K	0.01%	515

Other funds holding ELAN

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

SHCM

Sachem Head Capital Management New York $4.15B AUM 48.05% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Aristotle Capital Management Los Angeles, California $47.8B AUM 13.38% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Nomura Holdings Tokyo, Japan $37.7B AUM 34.44% 1-Year Est. Return

Winslow Evans & Crocker's ELAN Position: Q4 2020 in Review

Winslow Evans & Crocker opened a new position in Elanco Animal Health (ELAN) in Q4 2020: 2,380 shares worth $73K. The stake represents 0.01% of the portfolio and ranks #515 among its holdings.

440 funds tracked by Wall St. Rank hold ELAN as of Q4 2020.

Winslow Evans & Crocker held 2,380 shares of Elanco Animal Health worth $73K as of Q4 2020.
Elanco Animal Health was a new Winslow Evans & Crocker position in Q4 2020.
Elanco Animal Health made up 0.01% of Winslow Evans & Crocker's portfolio in Q4 2020, its #515 holding.
440 funds tracked by Wall St. Rank held Elanco Animal Health as of Q4 2020.

Based on Winslow Evans & Crocker's 13F filing for Q4 2020, filed 3 Feb 2021.